Replimune Group, Inc.
USD11.12
-0.09 (-0.76%)
CEO
Sushil Patel
IPO Date
2018-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.97
Prev. Close
$11.20
Day Low
$10.97
Day High
$12.49
52W Low
$1.50
52W High
$13.24
Market Cap
$0.92B
Volume
1.85M
| -2.4 |
| 31 Mar 2023 | FY | 0.0% | 0.0% | -31.4% | -27.0% | 0.11 | 17.52 | -5.9 |
| 31 Mar 2022 | FY | 0.0% | 0.0% | -28.7% | -25.6% | 0.08 | 19.46 | -7.5 |
| 31 Mar 2021 | FY | 0.0% | 0.0% | -16.2% | -14.9% | 0.07 | 33.25 | -17.4 |
| 31 Mar 2020 | FY | 0.0% | 0.0% | -28.6% | -22.5% | 0.23 | 14.68 | -6.5 |
| 31 Mar 2019 | FY | 0.0% | 0.0% | -22.4% | -20.0% | 0.05 | 14.26 | -11.7 |
| 31 Mar 2018 | FY | 0.0% | 0.0% | 70.2% | -30.2% | 0.00 | 12.53 | -23.7 |
| 31 Mar 2017 | FY | 0.0% | 0.0% | 66.9% | -33.8% | 0.00 | 11.29 | -42.3 |
| -1.2 |
| 30 Jun 2025 | Q1 | 0.0% | 0.0% | -25.7% | -18.5% | 0.23 | 6.94 | -2.5 |
| 31 Mar 2025 | Q4 | 0.0% | 0.0% | -17.8% | -13.4% | 0.18 | 7.95 | -2.6 |
| 31 Dec 2024 | Q3 | 0.0% | 0.0% | -13.8% | -11.0% | 0.16 | 11.43 | -3.8 |
| 30 Sept 2024 | Q2 | 0.0% | 0.0% | -13.9% | -10.6% | 0.20 | 10.11 | -4.1 |
| 30 Jun 2024 | Q1 | 0.0% | 0.0% | -12.6% | -10.1% | 0.18 | 13.46 | -3.0 |
| 31 Mar 2024 | Q4 | 0.0% | 0.0% | -14.7% | -11.3% | 0.20 | 10.72 | -2.2 |
| 31 Dec 2023 | Q3 | 0.0% | 0.0% | -12.1% | -9.6% | 0.18 | 12.40 | -2.7 |
| 30 Sept 2023 | Q2 | 0.0% | 0.0% | -12.9% | -10.7% | 0.13 | 12.76 | -4.7 |